================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: MAY 4, 2006
(date of earliest event reported)
ATS MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 0-18602
---------------------------
MINNESOTA 41-1595629
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation)
3905 ANNAPOLIS LANE N.
MINNEAPOLIS, MINNESOTA 55447
(Address of principal executive offices, including zip code)
(763) 553-7736
(Registrant's telephone number, including area code)
NOT APPLICABLE
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
(d) On May 3, 2006, the Board of Directors of ATS Medical, Inc. (the "Company")
elected a new director, Steven Anderson. Mr. Anderson has been
Vice-President, Corporate Assurance for Acorn Cardiovascular, a company
developing implantable therapies for the treatment of heart failure, since
2000. He has previously been an executive at St. Croix Medical, Inc. from
1998 to 2000 and at TUV Product Services from 1996 to 1998. There are no
arrangements or understandings between Mr. Anderson and any other persons
pursuant to which Mr. Anderson was selected as a director. Mr. Anderson
does not have a direct or indirect material interest in any currently
proposed transaction to which the Company is to be a party in which the
amount involved exceeds $60,000, nor has Mr. Anderson had a direct or
indirect material interest in any such transaction since the beginning of
the Company's last fiscal year.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ATS MEDICAL, INC.
By: /s/ John R. Judd
---------------------------
John R. Judd
Chief Financial Officer
Date: May 4, 2006